Page 885 - Robbins Basic Pathology by Vinay Kumar, Abul K. Abbas, Jon C. Aster
P. 885
Index
A morphology of 461b, 463f
pathogenesis of 461b, 462f
AAT (α1-antitrypsin deficiency) summary for 462b
clinical course of 632 Acute tubular injury (ATI)
inherited metabolic diseases and 631–632 clinical course of 538
morphology of 632b, 632f diseases affecting tubules/interstitium and
pathogenesis of 631b
537–538
Abdominal aortic aneurysm (AAA) morphology of 538b
clinical consequences of 346 pathogenesis of 537b–538b, 537f
morphology of 346b, 346f summary for 538b
Acute viral pericarditis 403b
Abdominal hernia 574 Adaptive immunity 99–100
Abetalipoproteinemia 580 Adenocarcinoma, clear cell 685
ABL 180 Adenocarcinoma, ductal 653b–654b
ABO incompatibility 254 Adenocarcinoma in situ (AIS)
Acalculous cholecystitis, acute 641 lung tumors and 506b–509b, 508f
Acetaminophen 284, 287 Adenocarcinoma of the colon
Achondroplasia 767–768 clinical features of 598–599, 599f, 600t
Acquired immunodeficiency syndrome (AIDS). See also Human colonic polyps and 596–599
epidemiology of 597–599, 597f–598f
immunodeficiency virus (HIV) morphology of 598b, 599f
epidemiology of 143–144 pathogenesis of 596t, 597b–598b
summary for 600b
mother-to-infant transmission of 144 Adenoma
parenteral transmission of 144 of the colon
sexual transmission of 144
etiology and pathogenesis of 144–149 morphology of 594b–595b, 595f
introduction to 143–153 summary for 600b
morphology of 152b of the thyroid
summary for 149b–150b clinical features of 730
Acquired metabolic and toxic disturbances introduction to 729–730
metabolic disorders as 835 morphology of 729b–730b, 730f
nutritional diseases as 835 pathogenesis of 729b
toxic disorders as 835–836 Adenoma, growth hormone producing 719–720
Actinic keratosis Adenoma, Hürthle cell 729b–730b
clinical features of 857 Adenomyosis 689
as epithelial lesions of the skin 862–863 summary for 691
morphology of 862b, 863f Adenosine triphosphate (ATP). See ATP
Acute lymphoblastic leukemia (ALL) Adenosquamous carcinoma 653b–654b
clinical features of 431 Adhesion 30t, 35–36, 35f, 36t
genetic features of 433 Adhesion receptor 64
immunophenotypic features of 433 Adipose tissue 304–305
laboratory findings in 431–433 Adrenal cortex
lymphoid neoplasms and 430–433 adrenal insufficiency and 757–759
morphology of 431b–433b, 433f adrenocortical hyperfunction and 752–757
pathogenesis of 431b adrenocortical neoplasms and 759
prognosis for 433 endocrine system and 752–759
Acute myeloid leukemia (AML) 431, 431b–433b. See also Acute Adrenal insufficiency (hypoadrenalism)
lymphoblastic leukemia (ALL) acute adrenocortical insufficiency and 757
classification of 444–445, 445t and the adrenal cortex 757–759
immunophenotype of 433f, 445 chronic adrenocortical insufficiency and 757–758
morphology of 433f, 444b, 445f secondary adrenocortical insufficiency and
as myeloid neoplasms 444–445 758–759
pathogenesis of 444b summary for 759b
prognosis for 445 Adrenal medulla
summary for 448–449 and endocrine system 760–761
Acute respiratory distress syndrome (ARDS) tumors of 760–761
acute lung injury and 461, 461t Adrenocortical adenoma 754f, 759b–760b
clinical features of 461 Adrenocortical carcinoma 759b–760b, 759f
Page numbers followed by “f” indicate figures, “t,” tables;
“b,” boxes.